Clinical Trial Update: Metabolic Mapping to Measure Retinal Metabolism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from the National Eye Institute on metabolic mapping to measure retinal metabolism in macular degeneration and diabetic retinopath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Macular Degeneration, Diabetic Retinopathy | Phase 2 | Status: COMPLETED